Latest Funding News

First Au Limited has completed the initial tranche of its $1.5 million private placement, issuing over 4 million shares, while the much larger second tranche awaits shareholder approval at the upcoming AGM.

Lithium Universe Limited has successfully raised $600,000 through the first tranche of its share placement, advancing its green lithium refinery ambitions in North America. A second tranche worth $1.1 million awaits shareholder approval, underpinning the company’s strategic growth plans.

Munro Climate Change Leaders Fund Active ETF (ASX – MCCL) has released an estimated cash distribution of 302.3 cents per unit for the fiscal year ending 30 June 2025, signaling investor returns amid evolving market conditions.

North Stawell Minerals reports promising high-grade gold intercepts at its Darlington target within the Stawell Mineralised Corridor, backed by a $3.6 million capital raise to accelerate exploration.

Duxton Farms announces a transformative merger with four private agricultural companies, alongside a $4 million fully underwritten placement and a special dividend, aiming to significantly expand its asset base and diversify its portfolio.

HyTerra Limited expands its Nemaha Project drilling program by adding a third well, McCoy 1, marking a shift to data-driven site selection. Early gas logs from Blythe 13-20 suggest promising hydrogen and helium presence, pending lab confirmation.

Adherium Limited has announced a partially underwritten entitlement offer aiming to raise approximately A$4.5 million through the issuance of new shares and options at a significant discount. The capital raise is designed to accelerate patient onboarding and product development for its respiratory monitoring technology.

Adherium Limited has successfully closed the institutional portion of its entitlement offer, increasing the raise to $4.492 million due to robust demand. The company now invites retail shareholders to participate as it advances its digital respiratory health solutions.

Percheron Therapeutics has licensed HMBD-002, a promising immuno-oncology monoclonal antibody targeting VISTA, from Hummingbird Bioscience, marking a strategic pivot after recent setbacks. The company plans to initiate phase II trials in 2026, aiming to advance this novel cancer therapy toward commercialisation.

Kinterra Capital has announced an all-cash $204 million takeover bid for New World Resources, offering a significant premium over a rival bid and recent trading prices. The move positions Kinterra to potentially gain full control of NWR, reshaping the company’s future.

Manuka Resources is progressing financing to restart its Wonawinta silver processing plant and is evaluating a promising gold cut-back at Mt Boppy to boost its Cobar Basin production plan.

QuickFee Limited has successfully completed an oversubscribed Share Purchase Plan, raising a total of A$1.532 million alongside a recent placement, positioning the fintech for accelerated loan book expansion in the US and Australia.